In This Week’s Issue:
 
1. Patient Groups: New Drug Pricing Executive Orders Would Import Discriminatory Metrics, see details below.
2. U.K. Physicians Offer Cautionary Tale for Importing Discriminatory Foreign Policies, see details below.
3. Avalere: IPI Would Not Reduce Out-of-Pocket Costs, click here to read the report.
4. New PAVE Paper on Patient-Centered Value Measures, click here to read the paper.
5. Value Assessment Should be Expanded to Incorporate Health Inequality, click here to read the article.
6. Webinar: Unpacking ICER’s Models Assessing COVID-19 Treatments, click here to view the webinar.
7. OCR Continues its Work to Resolve COVID-19 Discrimination Cases, see details below.
8. International News: What Happens in Countries Using QALYs and Cost-Based Thresholds to Determine Coverage? See below for more.
9. ICER's QALY-Based Study Topics: Hemophilia A, Sickle Cell Disease, Ulcerative Colitis, Cystic Fibrosis, Bladder Cancer, Opioid Treatments, High Cholesterol, Anemia in Chronic Kidney Disease, click here to provide patient input.
10. Upcoming Events and Webinars, see details below.
11. Medical Journal Articles, see details below.
12. AHRQ Effective Program Updates, see details below.  

​Today, the Administration released its anticipated Executive Order related to Medicare. Among its provisions, it would allow for the government to reference prescription drug prices established internationally, regardless of the metrics used by those countries or implications for access to care in those countries, for drugs covered under Medicare Part B. The Partnership to Improve Patient Care and several other organizations expressed strong opposition to this concept when it was originally proposed in 2018. 

In This Week’s Issue:
 
1. Policymakers Should Avoid Importing Discrimination Through Foreign Reference Pricing, see details below.
2. Value Assessment Should be Expanded to Incorporate Health Inequality, click here to read the article.
3. Webinar: Unpacking ICER’s Models Assessing COVID-19 Treatments, click here to view the webinar.
4. Patients Know the Value of Medicines, click here to read the article.
5. OCR Continues its Work to Resolve COVID-19 Discrimination Cases, see details below.
6. International News: What Happens in Countries Using QALYs and Cost-Based Thresholds to Determine Coverage? See below for more.
7. ICER's QALY-Based Study Topics: Hemophilia A, Sickle Cell Disease, Ulcerative Colitis, Cystic Fibrosis, Bladder Cancer, Opioid Treatments, High Cholesterol, Anemia in Chronic Kidney Disease, click here to provide patient input.
8. Upcoming Events and Webinars, see details below.
9. Medical Journal Articles, see details below.
10. AHRQ Effective Program Updates, see details below.  

In This Week’s Issue:
 
1. Webinar: Unpacking ICER’s Models Assessing COVID-19 Treatments, click here to view the webinar.
2. Experts and Advocates Oppose Importing Discrimination Through Foreign Reference Pricing, see details below.
3. Patients Know the Value of Medicines, click here to read the article.
4. Video: Bringing Patient Centered Outcomes Research to the CF Community, click here to view the video.
5. Dollars-and-Cents Calculations Should Not Figure in to Saving a Life, click here to read the full article from the Genetic Literacy Project.
6. OCR Settles Tennessee Case on COVID-19 Patient Non-Discrimination, see details below.
7. PIPC Submits Comment Letter to ICER on Draft Evidence Report for NASH, click here to read the letter.
8. International News: What Happens in Countries Using QALYs and Cost-Based Thresholds to Determine Coverage? See below for more.
9. ICER's QALY-Based Study Topics: Hemophilia A, Sickle Cell Disease, Ulcerative Colitis, Cystic Fibrosis, Bladder Cancer, Opioid Treatments, High Cholesterol, Anemia in Chronic Kidney Disease, click here to provide patient input.
10. Upcoming Events and Webinars, see details below.
11. Medical Journal Articles, see details below.
12. AHRQ Effective Program Updates, see details below.  

​In This Week’s Issue:
 
1. Webinar: Unpacking ICER’s Models Assessing COVID-19 Treatments, see details below.
 
2. Dollars-and-Cents Calculations Should Not Figure in to Saving a Life, click here to read the full article from the Genetic Literacy Project.
 
3. OCR Settles Tennessee Case on COVID-19 Patient Non-Discrimination, see details below.
4. Morning Consult: Cost-Effectiveness in Health Care Is Racist, click here to read the op-ed.
5. PIPC Submits Comment Letter to ICER on Draft Evidence Report for NASH, click here to read the letter.
6. Experts and Advocates Oppose Importing Discrimination Through Foreign Reference Pricing, see details below.
7. Cost Assessors Must Consider Novel Value Elements, click here to read the article.
8. International News: What Happens in Countries Using QALYs and Cost-Based Thresholds to Determine Coverage? See below for more.
9. ICER's QALY-Based Study Topics: Hemophilia A, Sickle Cell Disease, Ulcerative Colitis, Cystic Fibrosis, Bladder Cancer, Opioid Treatments, High Cholesterol, Anemia in Chronic Kidney Disease, click here to provide patient input.
10. Upcoming Events and Webinars, see details below.
11. Medical Journal Articles, see details below.
12. AHRQ Effective Program Updates, see details below.